Clincosm LogoSign in Get a demo

aml

Showing 26 - 50 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

Recruiting
  • MDS
  • AML
  • Amiens, France
  • +15 more
Jul 21, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

AML Trial in Hangzhou (CLL1+CD33 CAR-T)

Not yet recruiting
  • AML
  • CLL1+CD33 CAR-T
  • Hangzhou, China
    Mingming Zhang Zhang
Jul 19, 2022

AML Trial in Hangzhou (CLL1 CAR-T)

Not yet recruiting
  • AML
  • CLL1 CAR-T
  • Hangzhou, China
    The First Affiliated Hospital, Zhejiang University
Jul 17, 2022

AML Trial in Hangzhou (ADGRE2 CAR-T)

Not yet recruiting
  • AML
  • ADGRE2 CAR-T
  • Hangzhou, China
    Mingming Zhang Zhang
Jul 17, 2022

Defining Clinical Potential of Mass Response asBiomarker for

Recruiting
  • Stage III Breast Cancer
  • +5 more
    • Columbus, Georgia
      Columbus Regional Research Institute, John B. Amos Cancer Center
    Jul 13, 2022

    AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

    Recruiting
    • AML
    • +6 more
    • Gilbert, Arizona
    • +7 more
    Jul 8, 2022

    AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

    Recruiting
    • AML
    • Acute Myeloid Leukemia
    • Charlottesville, Virginia
      University of Virginia
    Jul 2, 2022

    Acute Myeloid Leukemia, AML, AML, Adult Recurrent Trial (flotetuzumab)

    No longer available
    • Acute Myeloid Leukemia
    • +2 more
    • flotetuzumab
    • (no location specified)
    May 24, 2022

    AML Trial in Wuhan (CAR--?dT cells)

    Recruiting
    • AML
    • CAR--γδT cells
    • Wuhan, Hubei, China
      Tongji Hospital
    May 24, 2022

    AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

    Recruiting
    • AML
    • +4 more
    • CD123-CAR T
    • +4 more
    • Memphis, Tennessee
    • +1 more
    May 10, 2022

    AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

    Recruiting
    • AML
    • +8 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 13, 2022

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      AML Trial in Moscow (allo-HSCT)

      Recruiting
      • AML
      • allo-HSCT
      • Moscow, Russian Federation
        National Research Center for Hematology
      Apr 14, 2022

      AML Trial in Aurora (Venetoclax, CC-486)

      Recruiting
      • AML
      • Aurora, Colorado
      • +1 more
      Apr 4, 2022

      AML, AML, Adult Trial in Indianapolis (TAK-659, Ixazomib)

      Terminated
      • AML
      • AML, Adult
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Cancer Center
      Mar 15, 2022

      AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

      Active, not recruiting
      • AML
      • Flotetuzumab dose escalation
      • +2 more
      • Duarte, California
      • +42 more
      Mar 7, 2022

      NSCLC, SCLC, CRPC Trial in Tianjin (JAB-8263)

      Recruiting
      • NSCLC
      • +7 more
      • Tianjin, Tianjin, China
        Tianjin
      Mar 11, 2022

      AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))

      Completed
      • AML
      • Cytarabine (Phase 1 only)
      • +3 more
      • Los Angeles, California
      • +16 more
      Feb 22, 2022

      AML, MDS Trial in Tianjin (SHR-1702)

      Active, not recruiting
      • AML
      • MDS
      • Tianjin, Tianjin, China
        Blood disease hospital of Chinese Academy of Medical Sciences
      Mar 7, 2022

      Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +8 more
      • Gilbert, Arizona
      • +23 more
      Feb 22, 2022

      AML Trial in Hangzhou (CLL1 CAR T-cells)

      Recruiting
      • AML
      • CLL1 CAR T-cells
      • Hangzhou, Zhejiang, China
      • +1 more
      Feb 13, 2022

      AML Trial in Hangzhou (CD38 CAR T-cells)

      Recruiting
      • AML
      • CD38 CAR T-cells
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Feb 13, 2022

      AML, MDS Trial in United States (APVO436)

      Recruiting
      • AML
      • MDS
      • APVO436
      • San Francisco, California
      • +11 more
      Feb 8, 2022

      Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

      Terminated
      • Leukemia, Myeloid, Acute
      • AML
      • Aurora, Colorado
      • +16 more
      Jan 18, 2022